In this review, we aimed to summarize the pathogenesis, diagnosis, and management of mechanical prosthetic valve thrombosis
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Prosthetic valve thrombosis is one of the major causes of primary valve failure, which can be life-threatening.
📊
Key Findings & Data:Multimodality imaging is necessary for determination of leaflet immobilization, cause of underlying pathology (thrombus versus pannus or both), and whether thrombolytic therapy attempt in the patient would be successful or surgery is needed.
💡
Conclusion & Impact:In this review, we aimed to summarize the pathogenesis, diagnosis, and management of mechanical prosthetic valve thrombosis
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Prosthetic valve thrombosis is one of the major causes of primary valve failure, which can be life-threatening. Multimodality imaging is necessary for determination of leaflet immobilization, cause of underlying pathology (thrombus versus pannus or both), and whether thrombolytic therapy attempt in the patient would be successful or surgery is needed. Current guidelines for the management of prosthetic valve thrombosis lack definitive class I recommendations due to lack of randomized controlled trials, and usually leave the choice of treatment to the clinician’s experience. In this review, we aimed to summarize the pathogenesis, diagnosis, and management of mechanical prosthetic valve thrombosis
🔖
Cite This Article
GÜRSOY, M. O., KALÇIK, M., YESİN, M., KARAKOYUN, S., BAYAM, E., GÜNDÜZ, S., ÖZKAN, M. (2016). A global perspective on mechanical prosthetic heart valve thrombosis: Diagnostic and therapeutic challenges. The Anatolian Journal of Cardiology, Cilt: 16 - Sayı: 12, 980–990. https://ajindex.com/articles/365468
Hermans H, Vanassche T, Herijgers P, Meuris B, Herregods MC, Van de Werf F, et al. Antithrombotic therapy in patients with heart valve prostheses. Cardiol Rev 2013; 21: 27-36
Grunkemeier GL, Rahimtoola SH. Artificial heart valves. Annu Rev Med 1990; 41: 251-63
Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994; 89: 635-41
Karthikeyan G, Math RS, Mathew N, Shankar B, Kalaivani M, Singh S, et al. Accelerated infusion of streptokinase for the treatment of left-sided prosthetic valve thrombosis: a randomized controlled trial. Circulation 2009; 120: 1108-14
Özkan M, Kaymaz C, Kırma C, Sönmez K, Özdemir N, Balkanay M, et al. Intravenous thrombolytic treatment of mechanical prosthetic valve thrombosis: a study using serial transesophageal echocardiography. J Am Coll Cardiol 2000; 35: 1881-9
Özkan M, Gündüz S, Biteker M, Astarcıoğlu MA, Çevik C, Kaynak E, et al. Comparison of different TEE-guided thrombolytic regimens for prosthetic valve thrombosis: The TROIA Trial. JACC Cardiovasc Imaging 2013; 6:206-16
Özkan M, Çakal B, Karakoyun S, Gürsoy OM, Çevik C, Kalçık M, et al. Thrombolytic therapy for the treatment of prosthetic heart valve thrombosis in pregnancy with low-dose, slow infusion of tissuetype plasminogen activator. Circulation 2013; 128: 532-40
Özkan M, Gündüz S, Gürsoy OM, Karakoyun S, Astarcıoğlu MA, Kalçık M, et al. A novel strategy in the management of PROsthetic Mechanical valve Thrombosis and the prEdictors of outcomE: the Ultra-slow PROMETEE trial. Am Heart J 2015; 170: 409-18
Castilho FM, De Sousa MR, Mendonça AL, Ribeiro AL, CáceresLóriga FM. Thrombolytic therapy or surgery for valve prosthesis thrombosis: systematic review and meta-analysis. J Thromb Haemost 2014; 12: 1218-28
Anderson JM, Schoen EJ. Interaction of blood with artificial surfaces. In: Butchart E, Bodnar E, eds. Thrombosis, Embolism and Bleeding. London, ICR Publishers, 1992. p.160-71
Horstkotte D, Aul C, Seipel L, Körfer R, Budde T, Schulte HD, et al. Effect of valve type and valve function on chronic intravascular hemolysis following mitral and aortic valve replacement using alloprostheses. Z Kardiol 1983; 72: 119-31
Gürsoy OM, Karakoyun S, Kalçık M, Gökdeniz T, Yesin M, Gündüz S, et al. Usefulness of novel hematologic inflammatory parameters to predict prosthetic mitral valve thrombosis. Am J Cardiol 2014; 113: 860-4